Drugs.com - Pharma Industry News

Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer

MONDAY, June 9, 2025 -- For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality of life, according to a study published online May...

Jun 9, 2025 - 19:00
 0
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
MONDAY, June 9, 2025 -- For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality of life, according to a study published online May...
Read More

Tags:

Previous Article

Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM

Next Article

Drop in Mental Health Scores Seen With Primary Open-Angle Glaucoma Diagnosis

Related Posts

Parental Education Tied to Cognitive Function in Middle-Aged, Older Adults

Parental Education Tied to Cognitive Function in Middle...

Jun 4, 2025  0

Atypical BMI Trajectory Detectable in Children as Early as Age 3.5 Years

Atypical BMI Trajectory Detectable in Children as Early...

Jun 6, 2025  0

ASCO: Maintenance Lurbinectedin + Atezolizumab Enhances Survival in Lung Cancer

ASCO: Maintenance Lurbinectedin + Atezolizumab Enhances...

May 27, 2025  0